Nanoparticle based siRNA therapeutics for ovarian cancer overcoming drug resistance and future directions.
Saved in:
| Title: | Nanoparticle based siRNA therapeutics for ovarian cancer overcoming drug resistance and future directions. |
|---|---|
| Authors: | Di Fonte R; Laboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco, 65, 70124, Bari, Italy., Bolognino I; Laboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco, 65, 70124, Bari, Italy., Sommonte F; Laboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco, 65, 70124, Bari, Italy., Serratì S; Laboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco, 65, 70124, Bari, Italy., Fasano R; Laboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco, 65, 70124, Bari, Italy., Arduino I; Department of Pharmacy-Pharmaceutical Sciences, University of Bari, 70125, Bari, Italy., Iacobazzi RM; Department of Pharmacy-Pharmaceutical Sciences, University of Bari, 70125, Bari, Italy., Denora N; Department of Pharmacy-Pharmaceutical Sciences, University of Bari, 70125, Bari, Italy., Perego P; Molecular Pharmacology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milano, Italy., Rossi G; Unit of Neurology V and Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133, Milano, Italy., Tosi D; Early Clinical Trial Unit, Medical Oncology Department, Institut régional du Cancer de Montpellier, Inserm U1194, Montpellier University, Montpellier, France.; Fondazione Gianni Bonadonna, 20154, Milano, Italy., Porcelli L; Laboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco, 65, 70124, Bari, Italy., Azzariti A; Laboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco, 65, 70124, Bari, Italy. a.azzariti@oncologico.bari.it. |
| Source: | Discover nano [Discov Nano] 2026 Mar 04; Vol. 21 (1). Date of Electronic Publication: 2026 Mar 04. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Nature Switzerland Country of Publication: Switzerland NLM ID: 9918540788706676 Publication Model: Electronic Cited Medium: Internet ISSN: 2731-9229 (Electronic) Linking ISSN: 27319229 NLM ISO Abbreviation: Discov Nano Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41779311 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Nanoparticle based siRNA therapeutics for ovarian cancer overcoming drug resistance and future directions. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Di+Fonte+R%22">Di Fonte R</searchLink>; Laboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco, 65, 70124, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Bolognino+I%22">Bolognino I</searchLink>; Laboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco, 65, 70124, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Sommonte+F%22">Sommonte F</searchLink>; Laboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco, 65, 70124, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Serratì+S%22">Serratì S</searchLink>; Laboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco, 65, 70124, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Fasano+R%22">Fasano R</searchLink>; Laboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco, 65, 70124, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Arduino+I%22">Arduino I</searchLink>; Department of Pharmacy-Pharmaceutical Sciences, University of Bari, 70125, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Iacobazzi+RM%22">Iacobazzi RM</searchLink>; Department of Pharmacy-Pharmaceutical Sciences, University of Bari, 70125, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Denora+N%22">Denora N</searchLink>; Department of Pharmacy-Pharmaceutical Sciences, University of Bari, 70125, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Perego+P%22">Perego P</searchLink>; Molecular Pharmacology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Rossi+G%22">Rossi G</searchLink>; Unit of Neurology V and Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Tosi+D%22">Tosi D</searchLink>; Early Clinical Trial Unit, Medical Oncology Department, Institut régional du Cancer de Montpellier, Inserm U1194, Montpellier University, Montpellier, France.; Fondazione Gianni Bonadonna, 20154, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Porcelli+L%22">Porcelli L</searchLink>; Laboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco, 65, 70124, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Azzariti+A%22">Azzariti A</searchLink>; Laboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco, 65, 70124, Bari, Italy. a.azzariti@oncologico.bari.it. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918540788706676%22">Discover nano</searchLink> [Discov Nano] 2026 Mar 04; Vol. 21 (1). <i>Date of Electronic Publication: </i>2026 Mar 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature+Switzerland%22">Springer Nature Switzerland </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9918540788706676 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2731-9229 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227319229%22">27319229 </searchLink><i>NLM ISO Abbreviation: </i>Discov Nano <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41779311 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s11671-026-04487-9 Languages: – Code: eng Text: English Titles: – TitleFull: Nanoparticle based siRNA therapeutics for ovarian cancer overcoming drug resistance and future directions. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Di Fonte R – PersonEntity: Name: NameFull: Bolognino I – PersonEntity: Name: NameFull: Sommonte F – PersonEntity: Name: NameFull: Serratì S – PersonEntity: Name: NameFull: Fasano R – PersonEntity: Name: NameFull: Arduino I – PersonEntity: Name: NameFull: Iacobazzi RM – PersonEntity: Name: NameFull: Denora N – PersonEntity: Name: NameFull: Perego P – PersonEntity: Name: NameFull: Rossi G – PersonEntity: Name: NameFull: Tosi D – PersonEntity: Name: NameFull: Porcelli L – PersonEntity: Name: NameFull: Azzariti A IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 03 Text: 2026 Mar 04 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2731-9229 Numbering: – Type: volume Value: 21 – Type: issue Value: 1 Titles: – TitleFull: Discover nano Type: main |
| ResultId | 1 |